 Bruce McCollister
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 5 | 2016 | 174 | 1.220 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1510 | 0.870 |
Why?
| | Salmonella Infections | 3 | 2016 | 51 | 0.650 |
Why?
| | Nitric Oxide | 5 | 2011 | 892 | 0.620 |
Why?
| | Ceftriaxone | 1 | 2016 | 17 | 0.590 |
Why?
| | beta-Lactamases | 1 | 2016 | 26 | 0.580 |
Why?
| | Bacteremia | 2 | 2016 | 161 | 0.580 |
Why?
| | Macrophages | 3 | 2007 | 1324 | 0.540 |
Why?
| | Escherichia coli Proteins | 1 | 2016 | 170 | 0.520 |
Why?
| | Bacterial Proteins | 6 | 2010 | 759 | 0.440 |
Why?
| | Aminoglycosides | 1 | 2011 | 15 | 0.400 |
Why?
| | Biological Transport | 1 | 2011 | 382 | 0.360 |
Why?
| | Salmonella enterica | 2 | 2007 | 53 | 0.330 |
Why?
| | Interferon-gamma | 3 | 2008 | 736 | 0.310 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2007 | 26 | 0.310 |
Why?
| | Nitrogen Oxides | 1 | 2007 | 56 | 0.310 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 190 | 0.300 |
Why?
| | Microbial Viability | 1 | 2007 | 81 | 0.300 |
Why?
| | Meningitis, Cryptococcal | 2 | 2018 | 28 | 0.300 |
Why?
| | Macrophage Activation | 1 | 2007 | 168 | 0.290 |
Why?
| | Abscess | 3 | 2015 | 75 | 0.280 |
Why?
| | Membrane Proteins | 3 | 2007 | 1055 | 0.270 |
Why?
| | Phagosomes | 1 | 2005 | 43 | 0.270 |
Why?
| | Skin Diseases, Bacterial | 2 | 2016 | 24 | 0.260 |
Why?
| | Skin Diseases | 2 | 2015 | 125 | 0.230 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2005 | 279 | 0.230 |
Why?
| | Pneumonia, Bacterial | 1 | 2023 | 110 | 0.220 |
Why?
| | Treatment Failure | 2 | 2016 | 341 | 0.170 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 346 | 0.160 |
Why?
| | Cryptococcosis | 1 | 2018 | 23 | 0.160 |
Why?
| | Hospitalization | 3 | 2016 | 1785 | 0.160 |
Why?
| | Prophages | 1 | 2016 | 4 | 0.150 |
Why?
| | Sepsis | 1 | 2023 | 531 | 0.150 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 394 | 0.150 |
Why?
| | Ciprofloxacin | 1 | 2016 | 24 | 0.150 |
Why?
| | Cryptococcus | 1 | 2016 | 8 | 0.150 |
Why?
| | Antigens, Fungal | 1 | 2016 | 26 | 0.140 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.140 |
Why?
| | Tissue Adhesives | 1 | 2016 | 18 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 548 | 0.140 |
Why?
| | Gelatin | 1 | 2016 | 35 | 0.140 |
Why?
| | Air Filters | 1 | 2015 | 2 | 0.140 |
Why?
| | Genome, Bacterial | 1 | 2016 | 109 | 0.140 |
Why?
| | Plasmids | 1 | 2016 | 355 | 0.130 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 302 | 0.130 |
Why?
| | Escherichia coli | 2 | 2016 | 758 | 0.130 |
Why?
| | Polyurethanes | 1 | 2015 | 37 | 0.130 |
Why?
| | Hysterectomy | 1 | 2016 | 117 | 0.130 |
Why?
| | Thrombin | 1 | 2016 | 143 | 0.130 |
Why?
| | Drug Users | 1 | 2015 | 39 | 0.130 |
Why?
| | Reactive Oxygen Species | 2 | 2008 | 576 | 0.130 |
Why?
| | Cellulitis | 1 | 2014 | 47 | 0.120 |
Why?
| | Substance Abuse, Intravenous | 1 | 2015 | 80 | 0.120 |
Why?
| | Mice | 7 | 2023 | 15520 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2016 | 482 | 0.110 |
Why?
| | Mice, Knockout | 3 | 2008 | 2680 | 0.100 |
Why?
| | Aged | 6 | 2023 | 19657 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2008 | 165 | 0.090 |
Why?
| | Enterotoxins | 1 | 1990 | 86 | 0.090 |
Why?
| | NADPH Oxidases | 2 | 2008 | 138 | 0.090 |
Why?
| | Animals | 8 | 2023 | 33381 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2062 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 1 | 2011 | 305 | 0.080 |
Why?
| | Shock, Septic | 1 | 1990 | 187 | 0.080 |
Why?
| | NADPH Dehydrogenase | 1 | 2008 | 8 | 0.080 |
Why?
| | Respiratory Burst | 1 | 2008 | 31 | 0.080 |
Why?
| | Flavoproteins | 1 | 2007 | 7 | 0.080 |
Why?
| | Hemeproteins | 1 | 2007 | 7 | 0.080 |
Why?
| | Peroxiredoxins | 1 | 2008 | 23 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2007 | 4908 | 0.080 |
Why?
| | Succinate Dehydrogenase | 1 | 2007 | 44 | 0.080 |
Why?
| | Salmonella Infections, Animal | 1 | 2008 | 38 | 0.080 |
Why?
| | Gangliosides | 1 | 2007 | 19 | 0.080 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 96 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 280 | 0.080 |
Why?
| | Phagocytes | 1 | 2007 | 91 | 0.080 |
Why?
| | Gastric Mucosa | 1 | 2007 | 45 | 0.080 |
Why?
| | Sphingolipids | 1 | 2007 | 62 | 0.070 |
Why?
| | Cytosol | 1 | 2007 | 221 | 0.070 |
Why?
| | Ceramides | 1 | 2007 | 104 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 205 | 0.070 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 942 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1200 | 0.070 |
Why?
| | DNA, Complementary | 1 | 2005 | 268 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2005 | 413 | 0.060 |
Why?
| | Immunologic Memory | 1 | 2007 | 313 | 0.060 |
Why?
| | Risk Factors | 5 | 2018 | 9000 | 0.060 |
Why?
| | RNA, Bacterial | 1 | 2005 | 175 | 0.060 |
Why?
| | Cathelicidins | 1 | 2023 | 39 | 0.060 |
Why?
| | Heparitin Sulfate | 1 | 2023 | 42 | 0.060 |
Why?
| | Oligosaccharides | 1 | 2023 | 54 | 0.060 |
Why?
| | Retrospective Studies | 6 | 2018 | 12978 | 0.060 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 412 | 0.060 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2023 | 78 | 0.060 |
Why?
| | Humans | 11 | 2023 | 118972 | 0.060 |
Why?
| | Female | 7 | 2018 | 61564 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1012 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1570 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 240 | 0.050 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 702 | 0.050 |
Why?
| | Middle Aged | 6 | 2018 | 27617 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2008 | 1178 | 0.050 |
Why?
| | Community-Acquired Infections | 2 | 2015 | 143 | 0.050 |
Why?
| | Adult | 6 | 2018 | 31512 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2018 | 3171 | 0.040 |
Why?
| | Hyponatremia | 1 | 2018 | 42 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 757 | 0.040 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 120 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 172 | 0.030 |
Why?
| | Colorado | 2 | 2016 | 4196 | 0.030 |
Why?
| | Health Facilities | 1 | 2015 | 75 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2018 | 422 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2016 | 6561 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 155 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 200 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 148 | 0.030 |
Why?
| | Hearing Loss | 1 | 2018 | 186 | 0.030 |
Why?
| | Wound Infection | 1 | 2014 | 31 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 521 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2023 | 3730 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1474 | 0.030 |
Why?
| | Male | 5 | 2018 | 57801 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1670 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1868 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1901 | 0.030 |
Why?
| | Cohort Studies | 2 | 2014 | 5116 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2326 | 0.030 |
Why?
| | Lung Diseases | 1 | 2018 | 718 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2015 | 523 | 0.020 |
Why?
| | Young Adult | 2 | 2016 | 10793 | 0.020 |
Why?
| | Culture Media | 1 | 1990 | 163 | 0.020 |
Why?
| | Immunity | 1 | 2010 | 129 | 0.020 |
Why?
| | Rabbits | 1 | 1990 | 780 | 0.020 |
Why?
| | Hypertension | 1 | 2018 | 1203 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2009 | 69 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2424 | 0.020 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 13 | 0.020 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 18 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2008 | 42 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 2008 | 67 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2009 | 314 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2010 | 300 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1440 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 940 | 0.020 |
Why?
| | Organ Specificity | 1 | 2007 | 278 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 446 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2016 | 2235 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 1864 | 0.020 |
Why?
| | United States | 1 | 2018 | 12555 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 18480 | 0.010 |
Why?
|
|
McCollister's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|